July 14, 2023
Immunomic Therapeutics is highlighted in Washington Business Journal’s cover story, “Life sciences funding is tough, but there are still avenues to money.” WBJ talks about how a financing roadblock hit the life sciences sector after a pandemic influx, but there are still avenues to money.
Click here to read: